Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai-Lan Koppermann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pathologie (Heidelberg, Germany)|April 15, 2024
[Molecular pathological analysis through the ages]Maria Walker, Eva-Maria Mayr, Mai-Lan Koppermann, et al.
The Oncologist|October 1, 2025
Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutationFabian Kleinhenz, Nicole Pfarr, Lisa Steinhelfer, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2025
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyGaëlle Lescuyer, Alexandre Harlé, Hari Shankar Kumar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pathologie (Heidelberg, Germany)|April 15, 2024
[Molecular pathological analysis through the ages]Maria Walker, Eva-Maria Mayr, Mai-Lan Koppermann, et al.
The Oncologist|October 1, 2025
Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutationFabian Kleinhenz, Nicole Pfarr, Lisa Steinhelfer, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2025
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyGaëlle Lescuyer, Alexandre Harlé, Hari Shankar Kumar, et al.
Pageof 1